Exclusive - Kurdish Opposition Party Says Politics, Arms Needed in Dealing with Tehran

Exclusive - Kurdish Opposition Party Says Politics, Arms Needed in Dealing with Tehran
TT

Exclusive - Kurdish Opposition Party Says Politics, Arms Needed in Dealing with Tehran

Exclusive - Kurdish Opposition Party Says Politics, Arms Needed in Dealing with Tehran

Since the formation of the Iraqi Kurdistan Region government in 1992, two anti-Iran parties, the Komala Party of Iranian Kurdistan and the Democratic Party of Iranian Kurdistan (KDPI), decided to suspend their armed activities against Iranian forces. They took the decision to respect the political situation in the Kurdish region and avoid giving Tehran the excuses to expand into the area.

In return, ruling parties in Kurdistan continued to provide financial support to the two anti-Iran opposition Kurdish parties.

Komala has posts based in mountainous terrain north of Sulaymaniyah, and the KDPI is based in the city of Koy Sanjaq, Erbil Governorate.

Over time, divisions led the KDPI to split into the Democratic Party of Iranian Kurdistan, led by Mustafa Hijri, the Kurdistan Democratic Party (PDK), led by Mostafa Mouloudi. Komala, meanwhile, split into three branches.

These parties stayed away from arms for 15 years, up until two years ago when the KPDI resumed its armed operations deep inside Iran. It has over the years dealt heavy blows to positions of the Iranian Revolutionary Guards that are deployed heavily in the Kurdish regions in Iran. The Iranian regime retaliates by assassinating KDPI leaders and fighters inside the Kurdistan region.

Komala, until this very day, maintains a military silence, despite having a significant number of trained and armed fighters with medium and light weapons at their disposal.

Association for Human Rights in Kurdistan of Iran (KMMK) official and Komala offshoot leader Omar Alikhanzadeh said that his party resumed armed activity against Iran from 2009 until late 2013, but found it “futile and useless when compared to political and civil action.”

“We are now adopting a large-scale political project aimed at mobilizing masses politically and offering wider prospects for anti-Iranian political action,” Alikhanzadeh told Asharq Al-Awsat.

Working to form an entity which has both military and political wings operating inside Iranian territory, Alikhanzadeh said that the Komala plans further training and rehabilitation of military forces in border areas.

Despite using charged rhetoric, Alikhanzadeh said that the time for direct confrontation with the Iranian regime has not yet come.

He elaborated further by saying that Komala-linked fighters lack an elemental strategic depth, proper logistics, and financial support.

Over more, he said that Kurdish opposition members have also suffered pressure practiced by the Iraqi Kurdistan government, which has cut off all funding to opposition parties.

Speaking on toppling the Iranian regime, the official said it has to be a public choice taken and carried out by Iranians with no external drivers.

“The collapse of the Iranian is inevitable. The Iranian public disagrees with the regime structure, especially over its blatant involvement in spurring regional chaos, instead of focusing on internal affairs, such as the deteriorating living standards.”

Summing up recent riots in Iran, Alikhanzadeh said that the regime’s shortcoming has instigated an unprecedented wave of rejection and discontent against the rulers of Tehran.

As for the prospects of rapprochement between conflicting Komala offshoots Alikhanzadeh said that there is hope.

“We recently formed a center for joint cooperation between all the opposing Kurdish forces and parties. We outlined joint efforts, especially on working together to topple the current Tehran regime and replace it with a democratic alternative instead.”



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.